Orostachys Japonicus Promotes Apoptosis in Cervical Cancer Cells through Modulation of NF-ΚB and ERK1/2 Pathways

Seon-Hee Kim^1, and Dong Seok Lee^1,

¹Department of Biomedical Laboratory Science, Inje University, Gimhae, Republic of Korea

Cite this paper:
Seon-Hee Kim and Dong Seok Lee. Orostachys Japonicus Promotes Apoptosis in Cervical Cancer Cells through Modulation of NF-ΚB and ERK1/2 Pathways. Journal of Food and Nutrition Research. 2025; 13(12):455-461. doi: 10.12691/jfnr-13-12-3

Abstract

Cervical cancer remains a significant global health burden, necessitating the development of safer and more effective therapeutic agents. Orostachys japonicus, a traditional medicinal herb, has shown promising anti-cancer activity, but its molecular mechanisms in cervical cancer cells have not been fully elucidated. We investigated the pro-apoptotic effects of the ethyl acetate fraction of O. japonicus (E-OJ) on HeLa cells and compared its activity to known phenolic constituents (kaempferol, quercetin, and gallic acid). Apoptosis was assessed by Annexin V/PI flow cytometry and DAPI staining. Western blot analysis was used to examine NF-κB and MAPK signaling pathways, as well as caspase-3 activation. The role of ERK signaling was further evaluated using the ERK-specific inhibitor U0126. E-OJ treatment induced significant, dose-dependent apoptosis in HeLa cells, accompanied by nuclear fragmentation and chromatin condensation. Compared to individual compounds, E-OJ exhibited greater apoptotic efficacy. Mechanistically, E-OJ suppressed NF-κB signaling by blocking nuclear translocation of the NF-κB p65 subunit. Among the MAPK pathways, only ERK1/2 was activated by E-OJ. Inhibition of ERK1/2 with U0126 attenuated caspase-3 cleavage, indicating that ERK signaling mediates E-OJ-induced apoptosis through a caspase-3-dependent mechanism. These findings suggest that E-OJ induces apoptosis in cervical cancer cells by suppressing NF-κB activation and promoting ERK1/2-mediated caspase-3 activation. The superior efficacy of E-OJ compared to its individual phenolic components highlights its therapeutic potential as a natural anti-cancer agent.

Keywords:
Orostachys japonicus cervical cancer apoptosis NF-κB ERK1/2

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Hull, R., Mbele, M., Makhafola, T., Hicks, C., Wang, S. M., Reis, R. M., Mehrotra, R., Mkhize-Kwitshana, Z., Kibiki, G., Bates, D. O., and Dlamini, Z. “Cervical cancer in low and middle-income countries”, Oncol Lett, 20(3), 2058-2074, Sep. 2020.
[2]	Vale, D. B., Teixeira, J. C., Braganca, J. F., Derchain, S., Sarian, L. O., and Zeferino, L. C., “Elimination of cervical cancer in low- and middle-income countries: Inequality of access and fragile healthcare systems”, Int J Gynaecol Obstet, 152(1), 7-11, Jan. 2021.
[3]	Tsuda, N., Watari, H., and Ushijima, K., “Chemotherapy and molecular targeting therapy for recurrent cervical cancer”, Chin J Cancer Res, 28(2), 241-253, Apr. 2016.
[4]	Chao, X., Fan, J., Song, X., You, Y., Wu, H., Wu, M., and Li, L. “Diagnostic strategies for recurrent cervical cancer: A cohort study”, Front Oncol, 10, 591253, Dec. 2020.
[5]	George, I. A., Chauhan, R., Dhawale, R. E., Iyer, R., Limaye, Limaye, S., Sankaranarayanan, R., Venkataramanan, R., and Kumar, P. “Insights into therapy resistance in cervical cancer”, Advances in Cancer Biology - Metastasis, 6, 100074, Dec. 2022.
[6]	Burmeister, C. A., Khan, S. F., Schafer, G., Mbatani, N., Adams, T., Moodley, J., and Prince, S. “Cervical cancer therapies: Current challenges and future perspectives”, Tumour Virus Res, 13, 200238, Apr. 2022.
[7]	Gavrilescu, L. C., and Denkers, E. Y. “Apoptosis and the balance of homeostatic and pathologic responses to protozoan infection”, Infect Immun, 71(11), 6109-6115, Nov. 2003.
[8]	Pistritto, G., Trisciuoglio, D., Ceci, C., Garufi, A., and D'Orazi, G., “Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies”, Aging (Albany NY), 8(4), 603-619, Apr. 2016.
[9]	Fernald, K., and Kurokawa, M., “Evading apoptosis in cancer”, Trends Cell Biol, 23(12), 620-633, Dec. 2013.
[10]	Verzella, D., Pescatore, A., Capece, D., Vecchiotti, D., Ursini, M. V., Franzoso, G., Alesse, E., and Zazzeroni, F., “Life, death, and autophagy in cancer: NF-κB turns up everywhere”, Cell Death & Disease, 11(3), 210, Mar. 2020.
[11]	Yue, J., and López, J. M., “Understanding MAPK signaling pathways in apoptosis”, Int J Mol Sci, 21(7), Mar. 2020.
[12]	Gaur, U., and Aggarwal, B.B., “Regulation of proliferation, survival and apoptosis by members of the TNF superfamily”, Biochem Pharmacol, 66(8), 1403-1408, Oct. 2003.
[13]	Zhang, W., and Liu, H. T., “MAPK signal pathways in the regulation of cell proliferation in mammalian cells”, Cell Research, 12(1), 9-18, Mar. 2002.
[14]	Jeong, J. H., Ryu, D. S., Suk, D. H., and Lee, D. S., “Anti-inflammatory effects of ethanol extract from Orostachys japonicus on modulation of signal pathways in LPS-stimulated RAW 264.7 cells”, BMB Rep, 44(6), 399-404, Jun. 2011.
[15]	Ryu, D. S., Lee, H. S., Lee, G. S., and Lee, D. S., “Effects of the ethylacetate extract of Orostachys japonicus on induction of apoptosis through the p53-mediated signaling pathway in human gastric cancer cells”, Biol Pharm Bull, 35(5), 660-665, 2012.
[16]	Park, H. J., Yang, H. J., Kim, K. H., and Kim, S. H., “Aqueous extract of Orostachys japonicus A. Berger exerts immunostimulatory activity in RAW 264.7 macrophages”, J Ethnopharmacol, 170, 210-217, Jul. 2015.
[17]	Lee, K. S., Kim, S. W., and Lee, H. S., “Orostachys japonicus induce p53-dependent cell cycle arrest through the MAPK signaling pathway in OVCAR-3 human ovarian cancer cells”, Food Sci Nutr, 6(8), 2395-2401, Oct. 2018.
[18]	Kim, J. H., Nam, G. S., Kim, S. H., Ryu, D. S., and Lee, D. S., “Orostachys japonicus exerts antipancreatic cancer activity through induction of apoptosis and cell cycle arrest in PANC-1 cells”, Food Sci Nutr, 7(11), 3549-3559, Sep. 2019.
[19]	Kwon, J. H., Kim, J. H., Ryu, D. S., Lee, H. J., and Lee, D. S., “Anticancer effect of the ethyl acetate fraction from Orostachys japonicus on MDA-MB-231 human breast cancer cells through extensive induction of apoptosis, cell cycle arrest, and antimetastasis”, Evid Based Complement Alternat Med, 2019, 8951510, Nov. 2019.
[20]	Ryu, D.S., Baek, G.O., Kim, E.Y., Kim, K.H., and Lee, D.S., “Effects of polysaccharides derived from Orostachys japonicus on induction of cell cycle arrest and apoptotic cell death in human colon cancer cells”, BMB Rep, 43(11), 750-755, 2010.
[21]	Kim, S. H., and Lee, D. S., “Orostachys japonicus induce caspase-dependent apoptosis in HeLa human cervical cancer cells”, Nutr Res Pract, 19(1), 131-142, Feb. 2025.
[22]	Dmitrieva, N. I., and Burg, M. B., “Analysis of DNA breaks, DNA damage response, and apoptosis produced by high NaCl”, Am J Physiol Renal Physiol, 295(6), F1678-F1688, Dec. 2008.
[23]	Mandelkow, R., Gumbel, D., Ahrend, H., Kaul, A., Zimmermann, U., Burchardt, M., and Stope, M. B. “Detection and quantification of nuclear morphology changes in apoptotic cells by fluorescence microscopy and subsequent analysis of visualized fluorescent signals”, Anticancer Res, 37(5), 2239-2244, May 2017.
[24]	Zou, J., Lei, T., Guo, P., Yu, J., Xu, Q., Luo, Y., Ke, R., and Huang, D. “Mechanisms shaping the role of ERK1/2 in cellular senescence (Review)”, Mol Med Rep, 19(2), 759-770, Nov. 2019.
[25]	Cagnol, S., and Chambard, J. C., “ERK and cell death: Mechanisms of ERK-induced cell death—apoptosis, autophagy and senescence”, FEBS J, 277(1), 2-21, Jan. 2010.
[26]	Wang, X., and Tournier, C., “Regulation of cellular functions by the ERK5 signalling pathway”, Cell Signal, 18(6), 753-760, Jun 2006.
[27]	Liu, J., Ma, L., Chen, X., Wang, J., Yu, T., Gong, Y., Ma, A., Zheng, L., and Liang, H. “ERK inhibition sensitizes cancer cells to oleanolic acid-induced apoptosis through ERK/Nrf2/ROS pathway”, Tumour Biol, 37(6), 8181-8187, Jun 2016.
[28]	Jung, G. H., Lee, J. H., Han, S. H., Woo, J. S., Choi, E. Y., Jeon, S. J., Han, E. J., Jung, S. H., Park, Y. S., Park, B. K., Kim, B. S., Kim, S. K., and Jung J, Y. “Chrysin induces apoptosis via the MAPK pathway and regulates ERK/mTOR-mediated autophagy in MC-3 cells”, Int J Mol Sci, 23(24), 15747, Dec. 2022.
[29]	Kyriakis, J. M., and Avruch, J., “Mammalian MAPK signal transduction pathways activated by stress and inflammation: A 10-year update”, Physiol Rev, 92(2), 689-737, Apr. 2012.
[30]	Kim, B. W., Lee, E. R., Min, H. M., Jeong, H. S., Ahn, J. Y., Kim, J. H., Choi, H. Y., Choi, H., Kim, E. Y., Park, S. P., and Cho, S. G. “Sustained ERK activation is involved in the kaempferol-induced apoptosis of breast cancer cells and is more evident under 3-D culture condition”, Cancer Biol Ther, 7(7), 1080-1089, Jul. 2008.
[31]	Yufang, W., Mingfang, L., Nan, H., and Tingting, W., “Quercetin-targeted AKT1 regulates the Raf/MEK/ERK signaling pathway to protect against doxorubicin-induced nephropathy in mice”, Tissue and Cell, 85, 102229, Dec. 2023.
[32]	Luo, J. L., Kamata, H., and Karin, M., “IKK/NF-κB signaling: Balancing life and death—a new approach to cancer therapy”, J Clin Invest, 115(10), 2625-2632, Oct. 2005.
[33]	Chen, B., Liu, J., Ho, T. T., Ding, X., and Mo, Y. Y., “ERK-mediated NF-κB activation through ASIC1 in response to acidosis”, Oncogenesis, 5(12), e279, Dec. 2016.